Shaping Dendrimers for Active Oxygen Delivery: An Emerging Strategy for Targeting Tumor Microenvironments

Musa Albatsh1

  • 1Faculty of Pharmacy, Middle East University, 11610 Amman, Jordan.

Die Pharmazie
|April 30, 2026
PubMed

Insights

Dendrimers can be engineered to deliver oxygen and reactive oxygen species (ROS) for cancer treatment, overcoming drug resistance and off-target effects. This review explores their design, applications, and future potential in cancer therapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Reactive oxygen species (ROS) play a dual role in cancer, acting as signaling molecules at low levels and cytotoxic agents at high levels.
  • Chemotherapy faces challenges like drug resistance and off-target effects, often exacerbated by the tumor microenvironment (e.g., hypoxia).
  • Nanocarriers targeting ROS offer a promising strategy to enhance cancer therapy efficacy.

Purpose of the Study:

  • To review the structural design of dendrimers for oxygen transport and conjugation with ROS-generating therapies.
  • To explore the therapeutic applications of ROS-based dendrimers in photodynamic therapy, radiotherapy, and chemotherapy.
  • To critically compare different dendrimer types, oxygen delivery strategies, drug loading, and outcomes, while discussing translational challenges.

Main Methods:

  • Review of existing literature on dendrimers for ROS-based cancer therapy.
  • Analysis of structural designs for oxygen transport and ROS conjugation.
  • Comparison of various dendrimer types, generations, and delivery strategies.
  • Evaluation of in vitro/in vivo outcomes, toxicity, biodistribution, and regulatory aspects.

Main Results:

  • Dendrimers can be engineered for oxygen transport and ROS delivery using strategies like oxygen carriers, enzyme functionalization, photosensitizers, metal ions, and surface modifications.
  • Previous studies primarily focused on micelles, neglecting the potential of dendrimers in ROS-based cancer nanomedicine.
  • This review provides a comprehensive comparison of dendrimer types, delivery methods, and therapeutic outcomes.

Conclusions:

  • Dendrimers represent a versatile platform for developing targeted ROS-based cancer therapies.
  • Engineered dendrimers can overcome limitations of conventional chemotherapy by addressing tumor hypoxia and improving drug delivery.
  • Further research into biodistribution, biocompatibility, and regulatory pathways is crucial for clinical translation.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K